Update in breast cancer screening

Journal of the Hong Kong College of Radiologists

Volumn 7, Issue 4, 2004, Pages 171-180

  Lam, H S ^a  

^a KWONG WAH HOSPITAL   (Hong Kong)

Author keywords

Breast neoplasms; Clinical protocols; Mammography; Mass screening

Indexed keywords

ESTROGEN;

AGE; BREAST BIOPSY; BREAST CANCER; BREAST EXAMINATION; CANCER RISK; CANCER SCREENING; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; ECHOMAMMOGRAPHY; FAMILY HISTORY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASS SCREENING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; RADIATION EXPOSURE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS;

EID: 20044380351     PISSN: 10295097     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2000, Cancer incidence, mortality and prevalence worldwide. International Agency for Research on Cancer, World Health Organization. Geneva: IARC Press; 2001.
2. Shapiro S, Venet W, Strax P, et al. Periodic screening for breast cancer: the health insurance plan project and its sequelae, 1963-1986. Baltimore: John Hopkins University Press; 1988.
3. Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 1988;297:943-948.
4. Nystrom L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993;341:973-978.
5. Tabar L, Fagerberg CJ, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1985;1:829-832.
6. Roberts MM, Alexander TI, Anderson TI, et al. Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet 1990;335:241-246.
7. Frisell J, Eklund G, Hellström L, et al. Randomized study of mammography screening - preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 1991;18:49-56.
8. Bjurstam N, Bjorneld L, Duffy SW, et al. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer 1997;80:2091-2099.
9. Miller AB, Baines CI, To T, Wall C. Canadian National Breast Screening Study: I. Breast cancer detection and death rates among women aged 40-49. Can Med Assoc J 1992;147:1459-1476.
10. Miller AB, Baines CI, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50-59. Can Med Assoc J 1992;147:1477-1488.
11. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-134.
12. Andersson I, Janzon L. Reduced breast cancer mortality in women under age 50: updated results from the Malmo Mammographic Screening Program. J Natl Cancer Inst Monogr 1997; 22:63-67.
13. Duffy SW, Tabar L. Screening mammography re-evaluated Lancet 2000;355:747-758.
14. Olsen O, Gotzsche PC. Screening for breast cancer with mammography. The Cochrane Database Syst Rev 2001;4: CD001877.
15. Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358:1340-1342.
16. Horton R. Screening mammography - an overview revisited. Lancet 2001;358:1284-1285.
17. Kolata G. Study sets off debate over mammograms' value. New York Times; 9 Dec 2001:1.
18. Kolata G. Expert panel cites doubts on mammogram's worth. New York Times; 24 Jan 2002.
19. American College of Radiology, American College of Radiology website; 2002, http://www.acr.org.
20. National Cancer Institute (NCI), United States. Statement on mammography screening. NCI; 2002, http://www.nci.nih.gov/newscenter/mammstatement31jan02.
21. An open letter to women and their physicians. New York Times; 31 Jan 2002.
22. Miettinen OS, Henschke CI, Pasmantier MW, Smith JP, Libby DM, Yankelevitz DF. Mammographic screening: no reliable supporting evidence? Lancet 2002;359:404-405.
23. Department of Health and Human Services (HHS), United States. HHS affirms value of mammography for detecting breast cancer. HHS; 2002, http://www.hhs.gov/news/press/2002pres/20020221.html.
24. International Agency for Research on Cancer (IARC). Mammography screening can reduce deaths from breast cancer. IARC; 19 Mar 2002, http://www.iarc.fr/ENG/Press_Releases/pr139a.html.
25. Nystrom L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002;359:909-919.
26. European Institute of Oncology. Statement from the Chair. European Institute of Oncology; 2002, http://www.ieo.it/inglese/didattica/state_1.htm.
27. US Preventive Services Task Force (USPSTF). Screening for Breast Cancer. USPSTF; 2002, http://www.ahrq.gov/clinic/uspstf/uspsbrca.htm.
28. Agency for Healthcare Research and Quality. Screening for breast cancer. Recommendations and rationale. Agency for Healthcare Research and Quality; 2002, http://www.ahrq.gov/clinic/3rduspstf/breastcancer/brcanrr.htm.
29. USPSTF. Recommendations and rationale: screening for Breast Cancer. USPSTF; 2002, http://www.ahrq.gov/clinic/3rduspstf/breastcancer/brcanrr.htm.
30. Tabar L, Vitak B, Chen HH, et al. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am 2000; 38:625-651.
31. Alexander FE, Anderson TJ, Brown HK, et al. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet 1999;353:1903-1908.
32. Frisell J, Lidbrink E, Hellstrom L, Rutqvist LE. Follow-up after 11 years: update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat 1997;45: 263-270.
33. Bjurstam N, Bjorneld L, Warwick J, et al. The Gothenburg Breast Screening Trial. Cancer 2003;97:2387-2396.
34. Miller AB, To T, Baines CJ, et al. Canadian National Breast Screening Study-1: Breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 2002;137:305-312.
35. Miller AB, To T, Baines CJ, et al. Canadian National Breast Screening study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2000;92:1490-1499.
36. Garne JP, Aspegren K, Balldin G, Ranstam J. Increasing incidence of and declining mortality from breast carcinoma Trends in Malmö, Sweden, 1961-1992. Cancer 1997;79:69-74.
37. Tabar L, Yen MF, Vitak B et al. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 2003;361: 1405-1410.
38. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality BMJ 2000;321:665-669.
39. Jonsson H, Nystrom L, Tornberg S, Lenner P. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer. J Med Screen 2001;8: 152-160.
40. Paci E, Duffy SW, Giorgi D, et al. Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990-96. Br J Cancer 2002;87:65-69.
41. Duffy SW, Tabar L, Chen HH, et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 2002;95:458-469.
42. American Cancer Society. American Cancer Society guidelines for breast screening: update 2003. Atlanta, GA: American Cancer Society; 2003.
43. National Health Service (NHS), United Kingdom. The NHS cancer plan 2003. London: NHS; 2003.
44. Morison BJ. Screening for breast cancer (including 1998 rewording), Canadian Task Force on Preventive Health Care, 2004, http://www.ctfphc.org.
45. Wang SC. The Singapore National Breast Screening Programme: principles and implementation. Arm Acad Med Singapore 2003; 32:466-476.
46. BreastScreen Australia. BreastScreen Australia achievement report 1997 and 1998. Sydney: BreastScreen Australia; 2000, http://www.aihw.gov.au/publications/index.cfm/title/5991.
47. International Breast Cancer Screening Network (IBSN). IBSN website, http://appliedresearch.cancer.gov/ibsn.
48. Blanks RG, Moss SM, Wallis MG. Use of two view mammography compared with one view in the detection of small invasive cancers: further results from the National Health Service breast screening programme J Med Screen 1997;4:98-101.
49. Barton MB, Harris R, Fletcher SW. The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA 1999;282:1270-1280.
50. Thomas DB, Gao DL, Ray RM, et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst Cancer Spectrum 2002;94:1445-1457.
51. Semiglazov VF, Moiseyenko VM, Bavli JL, et al. The role of breast self-examination in early breast cancer detection (results of the 5-years USSR/WHO randomized study in Leningrad). Eur J Epidemiol 1992;8:498-502.
52. Ciatto S, Del Turco MR, Morrone D, et al. Independent double reading of screening mammograms. J Med Screen 1995;2: 99-101.
53. Thurfjell EL, Lernevall K, Taube AA. Benefit of independent double reading in a population-based mammography screening program. Radiology 1994;191:241-244.
54. Beam C, Sullivan D, Layde P. Effect of human variability on independent double reading in screening mammography. Acad Radiol 1996;3:891-897.
55. Anttinen I, Pamilo M, Soiva M, Roiha M. Double reading of mammography screening films: one radiologist or two? Clin Radiol 1993;48:414-421.
56. United Kingdom National Health Service (NHS), Cancer Screening Programmes. Key research in breast screening. NHS; 2004, http://www.cancerscreening.nhs.uk/breastscreen/research.html#age-trial
57. The Breast Screening Frequency Trial Group. The frequency of breast cancer screening: results from the UKCCCR Randomised Trial. Eur J Cancer 2002;38:1458-1464.
58. Christiansen CL, Wang F, Barton MB, et al. Predicting the cumulative risk of false-positive mammograms. J Natl Cancer Inst 2000;92:1657-1666.
59. Lewin JM, Hendrick RE, D'Orsi CJ, et al, Comparison of full-field digital mammography with screen-film mammography for cancer detection: results of 4,945 paired examinations. Radiology 2001;218:873-880.
60. Warren-Burhenne LJ, Wood SA, D'Orsi CJ, et al. Potential contribution of computer-aided detection to the sensitivity of screening mammography. Radiology 2000;215:554-562.
61. Freer TW, Ulissey MJ. Screening mammography with computer-aided detection: prospective study of 12,860 patients in a community breast center. Radiology 2001;220:781-786.
62. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004;351: 427-437.